Clinical trial
Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men
NCT01686828 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men
- Lead sponsor
- University of Washington
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- December 31, 2017
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
androgen deficiency, insulin resistance, metabolic disease, obesity, type 2 diabetes mellitus